These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10068933)

  • 1. [An unusual hemorrhagic variant of Stevens-Johnson syndrome in an HIV-infected patient].
    Schmid MH; Elsner P
    Hautarzt; 1999 Jan; 50(1):52-5. PubMed ID: 10068933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole-induced Stevens-Johnson syndrome: a case report.
    Langlois MR; Derk F; Belczyk R; Zgonis T
    J Am Podiatr Med Assoc; 2010; 100(4):299-303. PubMed ID: 20660883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole.
    Douglas R; Spelman D; Czarny D; O'Hehir RE
    Clin Infect Dis; 1997 Dec; 25(6):1480. PubMed ID: 9431406
    [No Abstract]   [Full Text] [Related]  

  • 4. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
    Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
    Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
    [No Abstract]   [Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole-induced Steven Johnson syndrome in an HIV-infected patient.
    Taqi SA; Zaki SA; Nilofer AR; Sami LB
    Indian J Pharmacol; 2012; 44(4):533-5. PubMed ID: 23087524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxic epidermal necrolysis (Lyell syndrome), a lifethreatening emergency of introgenic origin].
    Piérard GE; Jennes S; Piérard-Franchimont C
    Rev Med Liege; 2016 Oct; 71(10):435-439. PubMed ID: 28383851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cotrimoxazole induced dermatitis and curative treatment of AIDS pneumocystosis].
    Caumes E
    Rev Mal Respir; 1996; 13(2):101-6. PubMed ID: 8711227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous artifactual disease represented as recurrent toxic epidermal necrolysis.
    Gowring LE; Johnson R; Hivnor CM; Henning JS
    Cutis; 2016 Sep; 98(3):E6-E7. PubMed ID: 27814420
    [No Abstract]   [Full Text] [Related]  

  • 10. Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.
    Dharamsi FM; Michener MD; Dharamsi JW
    J Emerg Med; 2015 May; 48(5):551-4. PubMed ID: 25433836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe adverse cutaneous reactions to drugs.
    Roujeau JC; Stern RS
    N Engl J Med; 1994 Nov; 331(19):1272-85. PubMed ID: 7794310
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection.
    Porteous DM; Berger TG
    Arch Dermatol; 1991 May; 127(5):740-1. PubMed ID: 1827245
    [No Abstract]   [Full Text] [Related]  

  • 13. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W; Stingl G; Wolff K
    Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson syndrome after erythromycin therapy while deployed at sea.
    Williams DA
    Mil Med; 2000 Aug; 165(8):636-7. PubMed ID: 10957862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patch testing in an unusual case of toxic epidermal necrolysis.
    Klein CE; Trautmann A; Zillikens D; Bröcker EB
    Contact Dermatitis; 1995 Dec; 33(6):448-9. PubMed ID: 8706422
    [No Abstract]   [Full Text] [Related]  

  • 16. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with AIDS.
    Belfort R; de Smet M; Whitcup SM; Pavesio C; Lottenberg C; Rubin B; Lopez JS; Nussenblatt R
    Cornea; 1991 Nov; 10(6):536-8. PubMed ID: 1782783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Wildermuth A
    JAAPA; 2020 Aug; 33(8):48-49. PubMed ID: 32740115
    [No Abstract]   [Full Text] [Related]  

  • 18. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme.
    Roujeau JC
    J Dermatol; 1997 Nov; 24(11):726-9. PubMed ID: 9433029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole.
    Rijal JP; Pompa T; Giri S; Bhatt VR
    BMJ Case Rep; 2014 Jul; 2014():. PubMed ID: 25008332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.